期刊文献+

脑梗死和冠心病患者血清同型半胱氨酸改变 被引量:4

Alterations of serum homocysteine levels in cerebral infarction and coronary heart disease
暂未订购
导出
摘要 目的 :了解西北地区脑梗死和冠心病等心脑血管疾病患者血清同型半胱氨酸 (homocysteine,Hcy)、血脂水平的关系 .方法 :采用荧光偏振免疫分析方法 ,对 34例脑梗死患者 ,5 8例冠心病患者及 1 2 2例健康人进行血清Hcy的检测 ,同时测定其血脂水平 .结果 :脑梗死患者血清Hcy水平为(30 .5± 1 5 .4 ) μmol·L-1 ,冠心病患者血清Hcy水平为 (2 5 .5±1 3.5 ) μmol·L-1 ,与正常对照 (1 4 .2± 6 .9) μmol·L-1 比较 ,具有显著性差异 (P <0 .0 1 ) .脑梗死和冠心病患者血清Hcy水平与血脂无明显相关 (P >0 .0 5 ) .结论 :高Hcy血症是脑梗死、冠心病等心脑血管疾病独立的致病因素 。 AIM: To investigate the alterations of serum homocysteine (Hcy) levels in cerebral infarction and coronary heart disease (CHD) in the northwest region and to evaluate the relationship between the serum Hcy levels and lipid levels. METHODS: Serum Hcy levels of 34 patients with cerebral infarction and 58 patients with CHD and 122 normal controls were measured by using fluorescence polarization immunoassay (FPIA) technology and their serum lipid levels examined by automatic biochemistry analyzer. RESULTS: The mean serum Hcy level was (30.5±15.4) μmol·L -1 for cerebral infarction patients, (25.5±13.5) μmol·L -1 for CHD, and (14.2±6.9) μmol·L -1 for normal subjects. Statistically, the mean serum Hcy levels of cerebral infarction and CHD patients were significantly higher than those of the normal subjects ( P <0.01). No significant correlation was found between the serum Hcy and serum lipid in cerebral infarction patients and CHD patients ( P > 0.05 ). CONCLUSION: Hyperhomocysteinaemia is an independent risk factor for cerebral infarction and CHD.
出处 《第四军医大学学报》 北大核心 2003年第23期2157-2158,共2页 Journal of the Fourth Military Medical University
关键词 同型半胱氨酸 血脂 脑梗死 冠心病 荧光偏振免疫分析 homocysteine serum lipid cerebral infarction coronary heart disease fluorescence polarization immunoassay
  • 相关文献

参考文献9

二级参考文献20

  • 1沈佐君,吴琳.高效毛细管电泳法快速测定血清中游离氨基酸[J].中华检验医学杂志,1998,22(3):22-25. 被引量:21
  • 2杨功焕,黄正京,谭健,陈爱平.我国人群的主要卫生问题——全国疾病监测死亡资料分析[J].中华流行病学杂志,1996,17(4):199-202. 被引量:169
  • 3周联生,周敏,赵玲莉.脑出血与8项血脂指标的关系探讨[J].中风与神经疾病杂志,1996,13(5):281-282. 被引量:16
  • 4许龙善 魏承毓.再度肆虐人类的传染病[M].亚洲医药出版社,1998.234-241.
  • 5[1]Kang SS, Wong RW, Malinow MR. Hyperhomocysteinemia as a risk factor for occlusive vascular disease[J].Annu Rev Nutr, 1992, 12∶ 279.
  • 6[2]Bouchey CJ, Beresford SA. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes[J].JAMA, 1995, 274(13)∶ 1049.
  • 7[3]Ubbink JB, Vermaak WJ. The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease[J].Klin Wochenschr, 1991, 69(12) ∶ 527.
  • 8[4]Moghadasion MH, McManus BM, Frohlich JJ. Homocysteine and coronary artery disease. Clinical evidence and genetic and metabolic background[J].Arch Intern Med, 1997, 157(20)∶ 2299.
  • 9Rao V L R,J Neurosci,2001年,21卷,1876页
  • 10Atsushi U,J Neurol Neurosurg Psychiatry,2000年,69卷,472页

共引文献86

同被引文献26

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部